December 20, 2017 / 10:31 PM / a year ago

BRIEF-FDA Accepts New Drug Application For Seysara (Sarecycline)

Dec 20 (Reuters) - Allergan Plc:

* FDA ACCEPTS NEW DRUG APPLICATION FOR SEYSARA™ (SARECYCLINE) FOR THE TREATMENT OF MODERATE TO SEVERE ACNE

* PARATEK PHARMACEUTICALS INC - ALLERGAN EXPECTS PRESCRIPTION DRUG USER FEE ACT ACTION DATE TO OCCUR IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below